MOTIVATION: Changes in the copy number of chromosomal DNA segments [copy number variants (CNVs)] have been implicated in human variation, heritable diseases and cancers. Microarray-based platforms are the current established technology of choice for studies reporting these discoveries and constitute the benchmark against which emergent sequence-based approaches will be evaluated. Research that depends on CNV analysis is rapidly increasing, and systematic platform assessments that distinguish strengths and weaknesses are needed to guide informed choice. RESULTS: We evaluated the sensitivity and specificity of six platforms, provided by four leading vendors, using a spike-in experiment. NimbleGen and Agilent platforms outperformed Illumina and Affymetrix in accuracy and precision of copy number dosage estimates. However, Illumina and Affymetrix algorithms that leverage single nucleotide polymorphism (SNP) information make up for this disadvantage and perform well at variant detection. Overall, the NimbleGen 2.1M platform outperformed others, but only with the use of an alternative data analysis pipeline to the one offered by the manufacturer. AVAILABILITY: The data is available from http://rafalab.jhsph.edu/cnvcomp/. CONTACT: pevsner@jhmi.edu; fspencer@jhmi.edu; rafa@jhu.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
MOTIVATION: Changes in the copy number of chromosomal DNA segments [copy number variants (CNVs)] have been implicated in human variation, heritable diseases and cancers. Microarray-based platforms are the current established technology of choice for studies reporting these discoveries and constitute the benchmark against which emergent sequence-based approaches will be evaluated. Research that depends on CNV analysis is rapidly increasing, and systematic platform assessments that distinguish strengths and weaknesses are needed to guide informed choice. RESULTS: We evaluated the sensitivity and specificity of six platforms, provided by four leading vendors, using a spike-in experiment. NimbleGen and Agilent platforms outperformed Illumina and Affymetrix in accuracy and precision of copy number dosage estimates. However, Illumina and Affymetrix algorithms that leverage single nucleotide polymorphism (SNP) information make up for this disadvantage and perform well at variant detection. Overall, the NimbleGen 2.1M platform outperformed others, but only with the use of an alternative data analysis pipeline to the one offered by the manufacturer. AVAILABILITY: The data is available from http://rafalab.jhsph.edu/cnvcomp/. CONTACT: pevsner@jhmi.edu; fspencer@jhmi.edu; rafa@jhu.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Authors: Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan Journal: Genome Res Date: 2007-10-05 Impact factor: 9.043
Authors: Matthew E Ritchie; Benilton S Carvalho; Kurt N Hetrick; Simon Tavaré; Rafael A Irizarry Journal: Bioinformatics Date: 2009-08-06 Impact factor: 6.937
Authors: John C Marioni; Natalie P Thorne; Armand Valsesia; Tomas Fitzgerald; Richard Redon; Heike Fiegler; T Daniel Andrews; Barbara E Stranger; Andrew G Lynch; Emmanouil T Dermitzakis; Nigel P Carter; Simon Tavaré; Matthew E Hurles Journal: Genome Biol Date: 2007 Impact factor: 13.583
Authors: D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson Journal: Nat Genet Date: 1998-10 Impact factor: 38.330
Authors: Johan Staaf; Johan Vallon-Christersson; David Lindgren; Gunnar Juliusson; Richard Rosenquist; Mattias Höglund; Ake Borg; Markus Ringnér Journal: BMC Bioinformatics Date: 2008-10-02 Impact factor: 3.169
Authors: Stefano Colella; Christopher Yau; Jennifer M Taylor; Ghazala Mirza; Helen Butler; Penny Clouston; Anne S Bassett; Anneke Seller; Christopher C Holmes; Jiannis Ragoussis Journal: Nucleic Acids Res Date: 2007-03-06 Impact factor: 16.971
Authors: Sharon J Diskin; Mingyao Li; Cuiping Hou; Shuzhang Yang; Joseph Glessner; Hakon Hakonarson; Maja Bucan; John M Maris; Kai Wang Journal: Nucleic Acids Res Date: 2008-09-10 Impact factor: 16.971
Authors: Clara Bodelon; Svetlana Vinokurova; Joshua N Sampson; Johan A den Boon; Joan L Walker; Mark A Horswill; Keegan Korthauer; Mark Schiffman; Mark E Sherman; Rosemary E Zuna; Jason Mitchell; Xijun Zhang; Joseph F Boland; Anil K Chaturvedi; S Terence Dunn; Michael A Newton; Paul Ahlquist; Sophia S Wang; Nicolas Wentzensen Journal: Carcinogenesis Date: 2015-12-09 Impact factor: 4.944
Authors: Robert B Scharpf; Terri H Beaty; Holger Schwender; Samuel G Younkin; Alan F Scott; Ingo Ruczinski Journal: BMC Bioinformatics Date: 2012-12-12 Impact factor: 3.169
Authors: Eitan Halper-Stromberg; Jared Steranka; Kathleen H Burns; Sarven Sabunciyan; Rafael A Irizarry Journal: Bioinformatics Date: 2014-02-04 Impact factor: 6.937
Authors: Kanika Kanchan; Kruthika Iyer; Lisa R Yanek; Ivan Carcamo-Orive; Margaret A Taub; Claire Malley; Kristin Baldwin; Lewis C Becker; Ulrich Broeckel; Linzhao Cheng; Chad Cowan; Matteo D'Antonio; Kelly A Frazer; Thomas Quertermous; Gustavo Mostoslavsky; George Murphy; Marlene Rabinovitch; Daniel J Rader; Martin H Steinberg; Eric Topol; Wenli Yang; Joshua W Knowles; Cashell E Jaquish; Ingo Ruczinski; Rasika A Mathias Journal: Stem Cell Res Date: 2020-05-06 Impact factor: 2.020
Authors: Lifeng Liang; Cassie T Wang; Xiaofang Sun; Lian Liu; Man Li; Craig Witz; Daniel Williams; Jason Griffith; Josh Skorupski; Ghassan Haddad; Jimmy Gill; Wei-Hua Wang Journal: PLoS One Date: 2013-04-16 Impact factor: 3.240